Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer Patients
Clinical trial NCT04425564 · COMPLETED
Trial details
- NCT number
- NCT04425564
- Sponsor
- National Cancer Institute, Egypt
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2017-06-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.